Well-quantified tuberculosis exposure is a reliable surrogate measure of tuberculosis infection

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 8, 2012, Pages 1033-1039

  Mandalakas, Anna M ^a,b,c   Kirchner, H L ^d   Lombard, C ^e   Walzl, G ^f   Grewal, H M S ^g,h   Gie, R P ^b   Hesseling, A C ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d GEISINGER MEDICAL CENTER   (United States)

^e SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^f UNIVERSITY OF STELLENBOSCH   (South Africa)

^g UNIVERSITY OF BERGEN   (Norway)

^h HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Children; Contact tracing; Latent tuberculosis infection; Pediatrics; Preventive therapy

Indexed keywords

BCG VACCINE; ISONIAZID; TUBERCULIN; TUBERCULOSTATIC AGENT;

AGE; ARTICLE; BACTERIUM CULTURE; CHILD; CONTACT EXAMINATION; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HOUSEHOLD; HUMAN; INFANT; INFECTION RISK; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MATERNAL WELFARE; MYCOBACTERIUM TUBERCULOSIS; PRESCHOOL CHILD; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELIABILITY; RISK ASSESSMENT; RISK FACTOR; SOUTH AFRICA; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; AGE FACTORS; ANTITUBERCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; CONTACT TRACING; DRUG ADMINISTRATION SCHEDULE; ENVIRONMENTAL EXPOSURE; FAMILY CHARACTERISTICS; FEMALE; HOUSING; HUMANS; INFANT; INTERFERON-GAMMA RELEASE TESTS; ISONIAZID; LOGISTIC MODELS; MALE; MYCOBACTERIUM TUBERCULOSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PRINCIPAL COMPONENT ANALYSIS; QUESTIONNAIRES; RADIOGRAPHY, THORACIC; RISK ASSESSMENT; RISK FACTORS; SOUTH AFRICA; SPUTUM; TIME FACTORS; TUBERCULOSIS, PULMONARY;

EID: 84863603839     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0027     Document Type: Article

References (32)

1. Nelson L J, Wells C D. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis 2004; 8: 636-647. (Pubitemid 38625076)
2. Marais B J, Gie R P, Schaaf H S, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004; 8: 392-402. (Pubitemid 38624845)
3. Mahairas G G, Sabo P J, Hickey M J, Singh D C, Stover C K. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 1996; 178: 1274-1282. (Pubitemid 26073382)
4. Harboe M, Oettinger T, Wiker H G, Rosenkrands I, Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 1996; 64: 16-22. (Pubitemid 26009335)
5. Lalvani A. Spotting latent infection: the path to better tuberculosis control. Thorax 2003; 58: 916-918. (Pubitemid 37392799)
6. Andersen P, Munk M E, Pollock J M, Doherty T M. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356: 1099-1104.
7. Wood P R, Jones S L. BOVIGAM: an in vitro cellular diagnostic test for bovine tuberculosis. Tuberculosis (Edinb) 2001; 81: 147-155. (Pubitemid 32500101)
8. Mandalakas A M, Detjen A K, Hesseling A C, Benedetti A, Menzies D. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis 2011; 15: 1018-1032.
9. Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361: 1168-1173. (Pubitemid 36398385)
10. Hesseling A C, Mandalakas A M, Kirchner H L, et al. Highly discordant T-cell responses in individuals with recent exposure to household tuberculosis. Thorax 2009; 64: 840-846.
11. Hill P C, Brookes R H, Adetifa I M, et al. Comparison of e nzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis. Pediatrics 2006; 117: 1542-1548. (Pubitemid 46071380)
12. Mandalakas A M, Hesseling A C, Chegou N N, et al. High level of discordant IGRA results in HIV-infected adults and children. Int J Tuberc Lung Dis 2008; 12: 417-423. (Pubitemid 351507255)
13. Nakaoka H, Lawson L, Squire S B, et al. Risk for tuberculosis among children. Emerg Infect Dis 2006; 12: 1383-1388. (Pubitemid 44455214)
14. Adetifa I M, Ota M O, Jeffries D J, et al. Commercial interferon gamma release assays compared to the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection in childhood contacts in the Gambia. Pediatr Infect Dis J 2010; 29: 439-443.
15. Mandalakas A, Detjen A, Hesseling A. Can we accurately diagnose tuberculosis infection in children? Pediatr Infect Dis 2011; 30: 817-818.
16. Kritzinger F E, den Boon S, Verver S, et al. No decrease in annual risk of tuberculosis infection in endemic area in Cape Town, South Africa. Trop Med Int Health 2009; 14: 136-142.
17. Shanaube K, Sismanidis C, Ayles H, et al. Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South Africa. PLoS One 2009; 4: e7749.
18. Corrigal J. Western Cape provincial EPI vaccination survey. Bellville, South Africa: University of the Western Cape, 2005. http://www.capegateway.gov. za/Text/2007/6/cd-volume-7-childhood-diseases-overview.pdf Accessed April 2012.
19. Oxford Immunotec. T-spot.TB. Oxford, UK: Oxford Immunotec, 2006. http://www.oxfordimmunotec.com/products-services/uses.html Accessed April 2012.
20. Cellestis. QuantiFERON®-TB Gold In-Tube. Carnegie, VIC, Australia: Cellestis, 2012. http://www.cellestis.com/IRM/Content/usa/qftproducts- tbgoldintube.html Accessed April 2012.
21. Marais B J, Gie R P, Hesseling A C, et al. A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Pediatrics 2006; 118: e1350-1359. (Pubitemid 46394446)
22. Marais B J, Gie R P, Schaaf H S, et al. A proposed radiological classification of childhood intra-thoracic tuberculosis. Pediatr Radiol 2004; 34: 886-894. (Pubitemid 39462398)
23. Cronbach L J. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334.
24. Woldehanna S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Databases Syst Rev 2004; (1): CD000171.
25. Smieja M, Marchetti C, Cook D, Smaill F. Isoniazid for preventing tuberculosis in non-HIV-infected persons. Cochrane Database Syst Rev 2000; (2): CD001363.
26. World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. WHO/HTM/TB/2006.371. Geneva, Switzerland: WHO, 2006.
27. Marais B J, van Zyl S, Schaaf H S, van Aardt M, Gie R P, Beyers N. Adherence to isoniazid preventive chemotherapy: a prospective community based study. Arch Dis Child 2006; 91: 762-765.
28. van Zyl S, Marais B J, Hesseling A C, Gie R P, Beyers N, Schaaf H S. Adherence to anti-tuberculosis chemoprophylaxis and treatment in children. Int J Tuberc Lung Dis 2006; 10: 13-18.
29. Guwatudde D, Nakakeeto M, Jones-Lopez E C, et al. Tuberculosis in household contacts of infectious cases in Kampala, Uganda. Am J Epidemiol 2003; 158: 887-898. (Pubitemid 37323251)
30. Alperstein G, Morgan K R, Mills K, Daniels L. Compliance with anti-tuberculosis preventive therapy among 6-year-old children. Aust NZ J Public Health 1998; 22: 210-213. (Pubitemid 28175067)
31. Schaaf H S, Marais B J, Whitelaw A, et al. Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Infect Dis 2007; 7: 140.
32. Cotton M F, Schaaf H S, Lottering G, Weber H L, Coetzee J, Nachman S. Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting. Int J Tuberc Lung Dis 2008; 12: 225-227. (Pubitemid 351212418)